Free Trial Information
BioCentury | Oct 8, 2020
Finance

Hillhouse’s Genor tops off busy year with IPO, plans to ‘transform’ pipeline

...Details were not disclosed.That same month Genor completed its series B, bringing in new investors Temasek, CR-CP Life Science Fund...
Read More
BioCentury | Aug 26, 2020
Deals

Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues

Connect raises $115M C round, eyes pivotal trialsRA Capital’s Derek DiRocco will join the board of Suzhou Connect Biopharmaceuticals Ltd. after the firm led the Chinese biotech’s $115 million series C round.  Additional new investors Lilly...
Read More
BioCentury | Jun 10, 2020
Deals

Deals for leading Chinese immuno-oncology companies: Innovent lands Roche as partner; JW raises $100M

...billion takeout of Celgene Corp. CPE and Mirae Asset co-led the round with participation from CR-CP Life Science Fund...
Read More
BioCentury | Jun 2, 2020
Finance

Hillhouse-backed $160M series B round to drive Genor’s first candidate to the market

...a $160 million series B round led by existing investor Hillhouse Capital. New investors Temasek, CR-CP Life Science Fund...
Read More
BioCentury | Jan 9, 2020
Financial News

Jan. 8 Financial Quick Takes: Intra-Cellular raises $295M; plus venture rounds for nference, Eyevensys, Transcenta, Airway, Progentec

...of its series B+, bringing the total amount raised in the round to $100 million. CR-CP Life Science Fund...
Read More
BioCentury | Jan 3, 2020
Financial News

Jan. 3 Financial Quick Takes: Black Diamond plots IPO; plus Oxford Nanopore, CF PharmTech, Mygene and Zerun

...a series E financing round led by New Alliance Capital. Also participating were new investors CR-CP Life Science Fund...
Read More
BioCentury | Dec 3, 2019
Financial News

Dec. 2 Financial Quick Takes: Kodiak gains on royalty deal; plus Clover, Aslan, Transcenta, EOC, Hui-Gene and ViGeneron

...B + Transcenta Holding Ltd. raised $80 million in a series B+ round co-led by CR-CP Life Science Fund...
Read More
BioCentury | Apr 29, 2019
Financial News

April 29 Quick Takes: Sirnaomics, Codiak, Cortexyme, Milestone, NextCure, Applied Therapeutics, Magenta

Sirnaomics closes $47M series C RNAi therapeutics company Sirnaomics Inc. (Gaithersburg, Md.) raised $22 million in a series C2 round led by Hong Kong-based CR-CP Life Sciences Fund, closing out its series C round for...
Read More
BioCentury | Feb 22, 2019
Finance

Accessing Hong Kong

...Leveraging its position in Hong Kong, the new CR-CP Life Science Fund aims to attract European and U.S. startups...
Read More
BioCentury | Feb 8, 2019
Company News

China Resources, Charoen Pokphand launch $300M life science fund

...China) and Thai conglomerate Charoen Pokphand Group (Bangkok, Thailand) launched the $300 million Hong Kong-based CR-CP Life Science Fund...
Read More
Items per page:
1 - 10 of 11
BioCentury | Oct 8, 2020
Finance

Hillhouse’s Genor tops off busy year with IPO, plans to ‘transform’ pipeline

...Details were not disclosed.That same month Genor completed its series B, bringing in new investors Temasek, CR-CP Life Science Fund...
Read More
BioCentury | Aug 26, 2020
Deals

Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues

Connect raises $115M C round, eyes pivotal trialsRA Capital’s Derek DiRocco will join the board of Suzhou Connect Biopharmaceuticals Ltd. after the firm led the Chinese biotech’s $115 million series C round.  Additional new investors Lilly...
Read More
BioCentury | Jun 10, 2020
Deals

Deals for leading Chinese immuno-oncology companies: Innovent lands Roche as partner; JW raises $100M

...billion takeout of Celgene Corp. CPE and Mirae Asset co-led the round with participation from CR-CP Life Science Fund...
Read More
BioCentury | Jun 2, 2020
Finance

Hillhouse-backed $160M series B round to drive Genor’s first candidate to the market

...a $160 million series B round led by existing investor Hillhouse Capital. New investors Temasek, CR-CP Life Science Fund...
Read More
BioCentury | Jan 9, 2020
Financial News

Jan. 8 Financial Quick Takes: Intra-Cellular raises $295M; plus venture rounds for nference, Eyevensys, Transcenta, Airway, Progentec

...of its series B+, bringing the total amount raised in the round to $100 million. CR-CP Life Science Fund...
Read More
BioCentury | Jan 3, 2020
Financial News

Jan. 3 Financial Quick Takes: Black Diamond plots IPO; plus Oxford Nanopore, CF PharmTech, Mygene and Zerun

...a series E financing round led by New Alliance Capital. Also participating were new investors CR-CP Life Science Fund...
Read More
BioCentury | Dec 3, 2019
Financial News

Dec. 2 Financial Quick Takes: Kodiak gains on royalty deal; plus Clover, Aslan, Transcenta, EOC, Hui-Gene and ViGeneron

...B + Transcenta Holding Ltd. raised $80 million in a series B+ round co-led by CR-CP Life Science Fund...
Read More
BioCentury | Apr 29, 2019
Financial News

April 29 Quick Takes: Sirnaomics, Codiak, Cortexyme, Milestone, NextCure, Applied Therapeutics, Magenta

Sirnaomics closes $47M series C RNAi therapeutics company Sirnaomics Inc. (Gaithersburg, Md.) raised $22 million in a series C2 round led by Hong Kong-based CR-CP Life Sciences Fund, closing out its series C round for...
Read More
BioCentury | Feb 22, 2019
Finance

Accessing Hong Kong

...Leveraging its position in Hong Kong, the new CR-CP Life Science Fund aims to attract European and U.S. startups...
Read More
BioCentury | Feb 8, 2019
Company News

China Resources, Charoen Pokphand launch $300M life science fund

...China) and Thai conglomerate Charoen Pokphand Group (Bangkok, Thailand) launched the $300 million Hong Kong-based CR-CP Life Science Fund...
Read More
Items per page:
1 - 10 of 11